Hem › Icke-småcellig lungcancer › Kansas › Kansas City
Kliniska studier för Icke-småcellig lungcancer i Kansas City, KS
11 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Kansas City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekryterarFas 1
- University of Kansas Medical Center, Kansas City
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekryterarFas 3
- University of Kansas Cancer Center, Kansas City
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- The University of Kansas Cancer Center, Kansas City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekryterarFas 1
- The University of Kansas Hospital, Kansas City
- The University of Kansas Medical Center Medical Office Building, Kansas City
- University of Kansas Hospital Cambridge North Tower A, Kansas City
- och 1 fler
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekryterarFas 2
- University of Kansas Cancer Center, Kansas City
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- University of Kansas Cancer Center, Kansas City
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2/3
- University of Kansas Cancer Center, Kansas City
- Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi bort
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- University of Kansas Cancer Center, Kansas City
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
RekryterarFas 1/2
- The University of Kansas Cancer Center, Westwood Campus, Kansas City
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
RekryterarObservationsstudie
- The University of Kansas Cancer Center, Westwood Campus, Kansas City
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
RekryterarObservationsstudie
- The University of Kansas Cancer Center, Westwood Campus, Kansas City
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Kansas City
- Hjärt-kärlsjukdom14 studier
- Hjärtsvikt13 studier
- Övervikt13 studier
- Interstitiella lungsjukdomar13 studier
- Cystisk fibros13 studier
- Bröstcancer12 studier
- Blåscancer12 studier
- Akut myeloid leukemi12 studier
- Prostatacancer12 studier
- Lungcancer11 studier
- KOL9 studier
- Astma8 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.